Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

House votes to extend telehealth benefits

The bill, Advancing Telehealth Beyond COVID–19 Act of 2022, extends telehealth flexibilities under Medicare that were initially authorized during the public health emergency relating to COVID-19.

Ancora Heart AccuCinch Ventricular Restoration System heart failure FDA

Regulatory Roundup: FDA clears AI-powered Apple Watch competitor, grants breakthrough designation to new heart failure device

Ancora Heart received the FDA’s breakthrough device designation for its AccuCinch Ventricular Restoration System, a new minimally invasive transcatheter device designed for the treatment of heart failure.

Thumbnail

Amazon’s $4B takeover of One Medical is already under fire

Within hours of Amazon announcing its intention to acquire healthcare provider One Medical for $3.9 billion in cash, lawmakers took aim at the retail giant to pursue blocking the deal.

insurance payer payment insurer

Providers ask for higher payments in OPPS proposed rule

The proposed payment increase of 2.7% doesn't make up for sequestration cuts, inflation, and other factors hitting hospitals, medical groups say. 

Thumbnail

Autoimmune patients caught in crossfire of Supreme Court's Roe decision

Some patients with certain autoimmune diseases are finding it difficult to obtain their prescriptions for methotrexate as a result of changing abortion care laws.

female physician male

Abortion care still protected in emergency situations for all Americans, Biden administration clarifies

The Biden administration has seemingly found a way to federally protect abortion care services in all states in some circumstances.

Medtronic recalls more than 1M dialysis catheters

This is a Class I recall, which means using the devices could cause "serious adverse health consequences or death."

notebook inspector

FDA to consider OTC birth control application

The application comes just weeks after the Supreme Court overturned Roe v. Wade, which guaranteed the right to abortion care in the U.S. for nearly 50 years.

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup